The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: A randomized controlled trial
Jean-Marc Chapplain(Centre Hospitalier Universitaire de Rennes), C. Michelet(Centre Hospitalier Universitaire de Rennes), Philippe Van de Perre(Inserm), Catherine Mouchel(Inserm), Bruno Turlin(Inserm), Alain Renault(Inserm), Éric Bellissant(Inserm), Dominique Guyader(Inserm), Isabelle Poizot‐Martin(Hôpital Sainte-Marguerite), Gilles Pialoux, Jean‐Michel Molina(Assistance Publique – Hôpitaux de Paris)
Cited by 6
Related Papers
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
|Journal of Biological Chemistry|2001|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894